بدائل البحث:
significantly point » significantly onto (توسيع البحث), significantly poorer (توسيع البحث), significantly lower (توسيع البحث)
point decrease » point increase (توسيع البحث)
sizes decrease » scores decreased (توسيع البحث), rivers decreased (توسيع البحث)
significantly point » significantly onto (توسيع البحث), significantly poorer (توسيع البحث), significantly lower (توسيع البحث)
point decrease » point increase (توسيع البحث)
sizes decrease » scores decreased (توسيع البحث), rivers decreased (توسيع البحث)
-
1
-
2
-
3
Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size.
منشور في 2025"…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …"
-
4
-
5
Supplementary Material for: Longitudinal Decrease in Left Ventricular Size with Age: Impact on Mortality and Cardiovascular Hospitalization
منشور في 2025"…Participants were categorized by LVEDD change from baseline: No Change (<5 mm), Decreased (≥5 mm), and Increased (≥5 mm). Results: A decrease in LVEDD was observed in 24% of participants (mean change -9±3 mm) and was significantly associated with older age, female sex, decreased volumes, concentric remodeling and diastolic dysfunction. …"
-
6
-
7
MiR-129-5p levels were decreased in mouse depression models.
منشور في 2025"…The Y-axis represents the fold change, while the X-axis indicates the significance of differential expression. The gray points represent miRNAs with no significant change (p < 0.05, false discovery rate (FDR) q < 0.05), while red and blue points indicate upregulated and downregulated miRNAs (p < 0.05, FDR q < 0.05), respectively. …"
-
8
-
9
Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index.
منشور في 2025"…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …"
-
10
-
11
Summary of post-treatment disease course measures from MDMA-AT publications.
منشور في 2025الموضوعات: -
12
-
13
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
منشور في 2025الموضوعات: -
14
-
15
-
16
-
17
Summary of post-treatment disease course measures from off-label medications clinical trials.
منشور في 2025الموضوعات: -
18
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
منشور في 2025الموضوعات: -
19
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
منشور في 2025الموضوعات: -
20
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
منشور في 2025الموضوعات: